5AM Venture Management »

Merus N V shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 522k 27.50

More positions owned by 5AM Venture Management

Enliven Therapeutics (ELVN)
Entrada Therapeutics (TRDA)
Pharvaris N V (PHVS)
Celldex Therapeutics Com New (CLDX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Biohaven (BHVN)
Disc Medicine (IRON)
Dianthus Therapeutics (DNTH)
Merus N V (MRUS)
Vor Biopharma (VOR)
Miragen Therapeutics (VRDN)
Mirati Therapeutics
Viking Therapeutics (VKTX)
Rallybio Corp (RLYB)
Tyra Biosciences (TYRA)

View all positions for 5AM Venture Management

Top funds holding Merus N V

Commodore Capital
Federated Investors
Samlyn Capital
Deerfield Management Company
BVF
VR Adviser
Wellington Management Company
Boxer Capital
Franklin Resources
Balyasny Asset Management
Medicxi Ventures Management
Lynx1 Capital Management
venBio Select Advisor
Frazier Life Sciences Management
Fairmount Funds Management

View all funds holding Merus N V